Trending/Neurosciences
New Alzheimer’s drug to be submitted to FDA for approval
Drug company Biogen Inc. intends to pursue regulatory approval from the Food and Drug Administration (FDA) for their experimental Alzheimer's drug, aducanumab, based on new…
October 21, 2019
October 15, 2019
October 11, 2019
Consumer Health: Why you need a flu shot if you have heart disease
October 9, 2019
October 7, 2019
September 30, 2019
September 29, 2019
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community